THE following papers describe "work in progress". They are intended to illustrate the kind of information which can be obtained by studying quantitatively the behaviour in the body of a macromolecule such as the polysaccharide dextran1. Dextran solution as a resuscitating fluid for the prevention and treatm-nent of shock is now familiar in many hospitals. Its value in this connexion is not under discussion here; its effectiveness, at least when manufactured to a close specification, is clear, though no doubt certain limitations will become more apparent with increasing experience. During 1948 we collaborated in the clinical trials of dextran (Bull et al., 1949) and certain facts claimed our attention: the urinary-c,&cLedr'cf a proportion of the dextran (the smaller molecules only): its slow removal from the plasma especially into the reticulo-endothelial system and lymph glands: alid a tendency for erythrocytes to aggregate in the presence of dextran (the effect being,gireater in higher concentrations and more marked with material greater than 100,000 id' molecular weight). The potential usefulness of such a macromolecule in experimental 'pathology became clear. Dextran can be prepared in a wide range of molecular size with similar chemical properties; it is electrically neutral, metabolically inert (np mammalian tissue extract is known to break it down), apparently non-toxic in high ooncentration, and can be estimated accurately after simple acid hydrolysis to glucose.
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Some examples of fundamental problems which can be studied with dextran can be given.
(1) The measurement of membrane permeabilitie).-The rate at which dextran molecules pass through a membrane can define permeability of many kinds of capillary, healthy and diseased. Filtration through the capillaries of the placenta, choroid plexus, ciliary body, joint-membranes and especially the renal glomerulus can be studied in this way, with a view to finding out the exact changes produced by various disease processes.
(2) The reticulo-endothelial system in normal animals is being studied, mainly by Dr. Maycock. Again, human studies in reticuloses and other diseases are called for.
(3) Nature of antigen-antibody reactions.-Dextran acts as a haptene toward the sera fromn animals immunized with Leuconostoc and certain other organisms. Dr. P. G. H. Gell has shown that the optimal propor-ion of dextran and antisera varies with molecular size.
(4) Cell surfaces differ in their behaviour from one another and with different macromolecules. For example, dextran, which causes marked erythrocyte aggregation, does not cause leucocytes to clump. Surface adsorption may be the mechanism of macromolecule removal by the reticulo-endothelial system, but this remains to be proved.
(5) Blood-clotting mechanismsdepend upon charged molecules and are unaffected by dextran.
Dextran derivatives such as the sulphate are highly charged, interacting and interfering with part of the reaction-chain involved in normal clotting. Again molecular size has been shown to be critical in determining the nature of these interactions.
From each of these pure research problems, useful clinical tests or remedies are likely to develop. As yet, only a start has been made in finding precise answers. Dextran preparations so far available, suffer from the defect of being somewhat disperse in molecular size, even when carefully prepared as "narrow cuts". We have been fortunate in our collaboration with Dr. and Mrs. C. Ricketts who have prepared fine fractions and derivatives, and suggested the further investigation of dextran sulphate previously described by Swedish workers. For membrane studies the high degree of asymmetry of the dextran molecule (of great advantage for investigating erythrocyte aggregation) makes I We wish to acknowledge the numerous gifts of dextran preparations by Messrs. Dextran Limited.
Proceedlings of the Royal Society of Medicine 8 interpretation somewhat difficult. We are left guessing as to whether the elongated molecule is likely to penetrate a membrane "pore" end-on, or sideways-on. Again, our chemical collaborators give promise of other series of polysaccharides-some even more elongated, others thought to be nearly spherical in molecular shape-which may assist in the solution of this kind of problem.
Medical Research Council Burns Unit, Birmingham AccidentHospital DEXTRAN is a polysaccharide formed during the growth of a coccus, Leuconostoc mesenterioides, on a medium containing sucrose. The normal habitat of the organism is rotting vegetable matter in which its growth was observed by Pasteur (1861). During its growth, the organism produces an exo-cellular enzyme which polymerizes the glucose portion of the sucrose in the medium (Hehre, 1948) to form dextran. The fructose portion of sucrose is set free. Growth in a medium containing 20 % sucrose results in conversion of about one-third of the available glucose to dextran.
Chemically, dextran differs from similar polysaccharides such as glycogen in that its glucose units are joined together through -1: 6 glucoside links. The main chain of glucose units so formed has short branches at frequent intervals which are probably joined through -1: 4 glucoside links (Stacey and Swift, 1948) . The dextrans produced by various strains of Leuconostoc differ in the extent of their branching (Jeanes and Wilham, 1950) . In their native state, the dextran chains are composed of about 200,000 glucose units, corresponding to a molecular weight of about 40 million. Such molecules are comparable in size with viruses.
Dextran has been widely used as a substitute for blood plasma in transfusions. For this purpose, the enormous natural molecules are quite unsuitable. Reduction in their size is effected by partial hydrolysis. Thereafter, a fractionation process allows gradation of molecular sizes and makes possible the selection of a sample containing the desired distribution of molecular size. Following the initial hydrolysis, the hydrolysate contains dextran molecules the largest of which are probably of molecular weight about one million and the smallest of molecular weight about ten thousand. This mixture is then submitted to fractional precipitation. When alcohol or acetone is added to such a solution and the temperature is slowly lowered, the larger molecules are precipitated first. This procedure allows the separation of a series of fractions (Ingelman and Halling, 1949; Ricketts, Lorenz and Maycock, 1950) . Each such fraction is more homogeneous than the mixture from which it is derived but every fraction still contains a range of molecular weights. Estimation of molecular weight.-The molecular weight of a polydisperse colloid may be expressed as a weight-average and as a number-average. Simple physical methods can be used to get an approximation to these averages for any dextran preparation but their more precise determination is more diffi'cult. The viscosity of a dextran solution, measured by timing the flow through an Ostwald viscometer allows the derivation of the intrinsic viscosity of the dextran by calculation. Ingelman and Halling (1949) have determined the relationship between intrinsic viscosity and molecular weight (the latter being calculated from ultracentrifuge measurements) for one kind of dextran. The osmotic pressure of a solution is proportional to the number-average molecular weight. To supplement the figures obtained by measurements of viscosity, osmotic pressure measurements have also been made using collodion membranes of the type described by Adair (1949) and this work is still in progress.
On the whole, the available evidence indicates that dextran molecules are longer and thinner than proteins of comparable molecular weights.
Dextran fractions for experimental use.-The dextrans used for the experiments subsequently to be described, varied in size from larger than fibrinogen to very much smaller than albumin. Fractions composed predominantly of molecules of the fibrinogen size were used to investigate the factors affecting the erythrocyte sedimentation rate. Fractions composed largely of molecules smaller than albumin were used to estimate the limits of permeability of the glomerular membrane.
Dextran sulphate.-This compound is an ester of sulphuric acid with dextran prepared by treating dextran with chlorosulphonic acid and pyridine. The free dextran sulphuric acid so obtained is only stable in solution but solid sodium, calcium and other salts can readily be prepared. These compounds display an anticoagulant action like that of heparin, which is itself the sulphuric ester of a polysaccharide composed of glucuronic acid and glucos'amine. The anticoagulant activity of sulphated polysaccharides has long been known
